| COVID-19: Prevention and control measures in community HR Güner, İ Hasanoğlu, F Aktaş Turkish Journal of medical sciences 50 (9), 571-577, 2020 | 1055 | 2020 |
| Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey MD Tanriover, HL Doğanay, M Akova, HR Güner, A Azap, S Akhan, ... The Lancet 398 (10296), 213-222, 2021 | 953 | 2021 |
| The first reactive arthritis case associated with COVID‐19 EM Saricaoglu, I Hasanoglu, R Guner Journal of Medical Virology 93 (1), 192, 2021 | 129 | 2021 |
| Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐19 B Kayaaslan, F Eser, AK Kalem, G Kaya, B Kaplan, D Kacar, I Hasanoglu, ... Journal of medical virology 93 (12), 6566-6574, 2021 | 128 | 2021 |
| Investigation of SARS-CoV-2 in semen of patients in the acute stage of COVID-19 infection B Kayaaslan, G Korukluoglu, I Hasanoglu, AK Kalem, F Eser, E Akinci, ... Urologia internationalis 104 (9-10), 678-683, 2020 | 121 | 2020 |
| Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg I Hasanoglu, G Korukluoglu, D Asilturk, Y Cosgun, AK Kalem, AB Altas, ... Infection 49, 117-126, 2021 | 118 | 2021 |
| Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients B Kayaaslan, F Eser, A Kaya Kalem, Z Bilgic, D Asilturk, I Hasanoglu, ... Mycoses 64 (9), 1083-1091, 2021 | 101 | 2021 |
| Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy R Guner, I Hasanoglu, S Keske, AK Kalem, MA Tasyaran Infection 39, 515-518, 2011 | 72 | 2011 |
| COVID-19 experience of the major pandemic response center in the capital: results ofthe pandemic's first month in Turkey HR GÜNER, İ Hasanoğlu, B Kayaaslan, A Aypak, AK Kalem, F Eser, ... Turkish journal of medical sciences 50 (8), 1801-1809, 2020 | 52 | 2020 |
| Portraying infective endocarditis: results of multinational ID-IRI study H Erdem, E Puca, Y Ruch, L Santos, N Ghanem-Zoubi, X Argemi, ... European Journal of Clinical Microbiology & Infectious Diseases 38, 1753-1763, 2019 | 52 | 2019 |
| Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load I Hasanoglu, R Guner, A Carhan, ZK Tufan, D Yagci-Caglayik, T Guven, ... Journal of Clinical Virology 75, 42-46, 2016 | 36 | 2016 |
| A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol AK Kalem, B Kayaaslan, S Neselioglu, F Eser, I Hasanoglu, A Aypak, ... Free Radical Biology and Medicine 166, 11-17, 2021 | 32 | 2021 |
| Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever? R Guner, I Hasanoglu, MA Tasyaran, D Yapar, S Keske, T Guven, ... Vector-Borne and Zoonotic Diseases 14 (8), 601-605, 2014 | 30 | 2014 |
| SARS-COV-2: prevention and control measures in community R Güner, I Hasanoğlu, F Aktaş Turk. J. Med. Sci 50, 571-577, 2020 | 25 | 2020 |
| Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir R Guner, I Hasanoglu, B Kayaaslan, A Aypak, E Akinci, H Bodur, F Eser, ... Journal of Infection and Public Health 14 (3), 365-370, 2021 | 24 | 2021 |
| Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients B Kayaaslan, A Kaya Kalem, D Asilturk, B Kaplan, G Dönertas, ... Mycoses 65 (5), 508-516, 2022 | 22 | 2022 |
| A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever ZK Tufan, I Hasanoglu, S Kolgelier, M Alisik, M Ergin, GR Yilmaz, ... Redox Report 22 (6), 241-245, 2017 | 22 | 2017 |
| Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain? PC Matthews, C Campbell, O Săndulescu, M Matičič, SM Ruta, ... Frontiers in pharmacology 13, 1062408, 2022 | 21 | 2022 |
| Which hematological markers have predictive value as early indicators of severeCOVID-19 cases in the emergency department? İ Şan, E Gemcioğlu, M Davutoğlu, R Çatalbaş, B Karabuğa, E Kaptan, ... Turkish Journal of Medical Sciences 51 (6), 2810-2821, 2021 | 16 | 2021 |
| Evaluating the efficiency of public policy measures against COVID-19 HR Güner, I Hasanoğlu, F Aktaş Turkish journal of medical sciences 51 (7), 3229-3237, 2021 | 15 | 2021 |
